Cutaneous lupus erythematosus: Update of therapeutic options: Part i

Journal of the American Academy of Dermatology

Volumn 65, Issue 6, 2011, Pages

  Kuhn, Annegret ^a   Ruland, Vincent ^a   Bonsmann, Gisela ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

antimalarials; first line treatment; lupus erythematosus; photoprotection; skin; smoking; sunscreens; treatment

Indexed keywords

ANTIMALARIAL AGENT; ASF 1096; BETAMETHASONE; CALCINEURIN INHIBITOR; CHLOROQUINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; COSMETIC; DAPSONE; HYDROXYCHLOROQUINE; IMIQUIMOD; MEPACRINE; METHOTREXATE; METHYLPREDNISOLONE; PIMECROLIMUS; PLACEBO; RETINOIC ACID; RETINOID; SALBUTAMOL; SUNSCREEN; TACROLIMUS; TAZAROTENE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; APLASTIC ANEMIA; ARTICLE; CIGARETTE SMOKING; CORTICOSTEROID THERAPY; CRYOTHERAPY; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; ECZEMA; EYE TOXICITY; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; NAUSEA; NERVOUSNESS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PSYCHOSIS; RASH; SEIZURE; SIDE EFFECT; SKIN LUPUS ERYTHEMATOSUS; SKIN PROTECTION; SYSTEMIC THERAPY; TREATMENT PLANNING; ULTRAVIOLET A RADIATION; VOMITING;

EID: 81155134221     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.06.018     Document Type: Review

References (113)

1. S. Jessop, D.A. Whitelaw, and F.M. Delamere Drugs for discoid lupus erythematosus Cochrane Database Syst Rev 4 2009 CD002954
2. T.Y. Tzung, Y.S. Liu, and H.W. Chang Tacrolimus vs clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study Br J Dermatol 156 2007 191 192
3. G.B. Jemec, S. Ullman, M. Goodfield, A. Bygum, A.B. Olesen, and J. Berth-Jones A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus Br J Dermatol 161 2009 1365 1370
4. W.W. Ting, and R.D. Sontheimer Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations Lupus 10 2001 171 184 (Pubitemid 32410073)
5. A. Kuhn, M. Sonntag, D. Richter-Hintz, C. Oslislo, M. Megahed, and T. Ruzicka Phototesting in lupus erythematosus: a 15-year experience J Am Acad Dermatol 45 2001 86 95 (Pubitemid 32655700)
6. E. Schmidt, H.P. Tony, E.B. Brocker, and C. Kneitz Sun-induced life-threatening lupus nephritis Ann N Y Acad Sci 1108 2007 35 40 (Pubitemid 47528716)
7. R.S. Stern, and W. Docken An exacerbation of SLE after visiting a tanning salon JAMA 255 1986 3120
8. P.J. Hampton, P.M. Farr, B.L. Diffey, and J.J. Lloyd Implication for photosensitive patients of ultraviolet A exposure in vehicles Br J Dermatol 151 2004 873 876 (Pubitemid 39482122)
9. J.A. Johnson, and R.M. Fusaro Broad-spectrum photoprotection: the roles of tinted auto windows, sunscreens and browning agents in the diagnosis and treatment of photosensitivity Dermatology 185 1992 237 241
10. L.R. Klein, C.A. Elmets, and J.P. Callen Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier Arthritis Rheum 38 1995 1152 1156
11. R.S. Klein, R.M. Sayre, J.C. Dowdy, and V.P. Werth The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus Autoimmun Rev 8 2009 320 324
12. R.S. Klein, V.P. Werth, J.C. Dowdy, and R.M. Sayre Analysis of compact fluorescent lights for use by patients with photosensitive conditions Photochem Photobiol 85 2009 1004 1010
13. C.L. Hexsel, S.D. Bangert, A.A. Hebert, and H.W. Lim Current sunscreen issues: 2007 Food and Drug Administration sunscreen labeling recommendations and combination sunscreen/insect repellent products J Am Acad Dermatol 59 2008 316 323
14. A. Faurschou, and H.C. Wulf The relation between sun protection factor and amount of suncreen applied in vivo Br J Dermatol 156 2007 716 719 (Pubitemid 46452341)
15. H. Stege, M.A. Budde, S. Grether-Beck, and J. Krutmann Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test Photodermatol Photoimmunol Photomed 16 2000 256 259
16. H. Stege, M.A. Budde, S. Grether-Beck, A. Richard, A. Rougier, and J. Krutmann Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test Eur J Dermatol 12 2002 VII IX
17. T. Herzinger, G. Plewig, and M. Rocken Use of sunscreens to protect against ultraviolet-induced lupus erythematosus Arthritis Rheum 50 2004 3045 3046 (Pubitemid 39209544)
18. Kuhn A, Gensch K, Meuth A, Boyer F, Dupuy P, Lehmann P, et al. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle controlled double-blind study. J Am Acad Dermatol. in press
19. L.M. Vila, A.M. Mayor, A.H. Valentin, S.I. Rodriguez, M.L. Reyes, and E. Acosta Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus P R Health Sci J 18 1999 89 94
20. C. Cusack, C. Danby, J.C. Fallon, W.L. Ho, B. Murray, and J. Brady Photoprotective behavior and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus Photodermatol Photoimmunol Photomed 24 2008 260 267
21. H.H. Roenigk Jr., J.S. Martin, P. Eichorn, and J.N. Gilliam Discoid lupus erythematosus: diagnostic features and evaluation of topical corticosteroid therapy Cutis 25 1980 281 285 (Pubitemid 10128832)
22. S. Jessop, and D. Whitelaw Cutaneous lupus erythematosus H. Williams, M. Bigby, T. Diepgen, A. Herxheimer, L. Naldi, B. Rzany, Evidence-based dermatology 2008 Blackwell Publishing Malden, MA 549 558
23. P. Lehmann Topical treatment of cutaneous lupus erythematosus A. Kuhn, P. Lehmann, T. Ruzicka, Cutaneous lupus erythematosus 2004 Springer Berlin 337 345
24. A. Kuhn, M. Haust, and G. Bonsmann Cutaneous lupus erythematosus-recent clinical, diagnostic and therapeutical aspects CME Dermatologie 2 2006 24 35
25. D.P. McCauliffe Cutaneous lupus erythematosus Semin Cutan Med Surg 20 2001 14 26 (Pubitemid 32230273)
26. M. Sardy, T. Ruzicka, and A. Kuhn Topical calcineurin inhibitors in cutaneous lupus erythematosus Arch Dermatol Res 301 2009 93 98
27. U. Wollina, and G. Hansel The use of topical calcineurin inhibitors in lupus erythematosus: an overview J Eur Acad Dermatol Venereol 22 2008 1 6
28. T.G. Tzellos, and D. Kouvelas Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation Eur J Clin Pharmacol 64 2008 337 341
29. M. Boehm, M. Gaubitz, T.A. Luger, D. Metze, and G. Bonsmann Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus: a report of three cases Dermatology 207 2003 381 385 (Pubitemid 37505787)
30. D. Bacman, A. Tanbajewa, M. Megahed, T. Ruzicka, and A. Kuhn Topical treatment with tacrolimus in lupus erythematosus tumidus [in German] Hautarzt 54 2003 977 979 (Pubitemid 37243390)
31. T. Yoshimasu, T. Ohtani, T. Sakamoto, A. Oshima, and F. Furukawa Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis Eur J Dermatol 12 2002 50 52 (Pubitemid 34131138)
32. M. Sugano, Y. Shintani, K. Kobayashi, N. Sakakibara, I. Isomura, and A. Morita Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus J Dermatol 33 2006 887 891 (Pubitemid 44813793)
33. S.L. Walker, B. Kirby, and R.J. Chalmers The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus Br J Dermatol 147 2002 405 406
34. V. Madan, P.J. August, and R.J. Chalmers Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study Clin Exp Dermatol 35 2010 27 30
35. A. Kuhn, K. Gensch, M. Haust, S. Schneider, G. Bonsmann, and N. Gaebelein A multicenter, randomized, double-blind, vehicle-controlled trial of tacrolimus 0.1% ointment in cutaneous lupus erythematosus Ann Rheum Dis 68 2009 70
36. A.K. Gupta, and M. Chow Pimecrolimus: a review J Eur Acad Dermatol Venereol 17 2003 493 503 (Pubitemid 37138884)
37. A. Kreuter, T. Gambichler, F. Breuckmann, F.M. Pawlak, M. Stucker, and A. Bader Pimecrolimus 1% cream for cutaneous lupus erythematosus J Am Acad Dermatol 51 2004 407 410 (Pubitemid 39178668)
38. A. Tlacuilo-Parra, E. Guevara-Gutierrez, F. Gutierrez-Murillo, A. Soto-Ortiz, F. Barba-Gomez, and M. Hernandez-Torres Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus Rheumatology (Oxford) 44 2005 1564 1568 (Pubitemid 41742477)
39. K.R. Edwards, and W.A. Burke Treatment of localized discoid lupus erythematosus with tazarotene J Am Acad Dermatol 41 1999 1049 1050
40. E. Seiger, S. Roland, and S. Goldman Cutaneous lupus treated with topical tretinoin: a case report Cutis 47 1991 351 355
41. R. Gerdsen, J. Wenzel, M. Uerlich, T. Bieber, and W. Petrow Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod Dermatology 205 2002 416 418 (Pubitemid 35356776)
42. U. Gul, M. Gonul, S.K. Cakmak, A. Kilic, and M. Demiriz A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5% Adv Ther 23 2006 787 792 (Pubitemid 44955859)
43. H.C. Wulf, and S. Ullman Discoid and subacute lupus erythematosus treated with 0.5% R-salbutamol cream Arch Dermatol 143 2007 1589 1590 (Pubitemid 350277785)
44. A. Kuhn, P.M. Becker-Wegerich, T. Ruzicka, and P. Lehmann Successful treatment of discoid lupus erythematosus with argon laser Dermatology 201 2000 175 177
45. H. Ueki Koebner phenomenon in lupus erythematosus with special consideration of clinical findings Autoimmun Rev 4 2005 219 223 (Pubitemid 40704706)
46. H. Zachariae, P. Bjerring, and M. Cramers Argon laser treatment of cutaneous vascular lesions in connective tissue diseases Acta Derm Venereol 68 1988 179 182 (Pubitemid 18097264)
47. W. Nurnberg, B. Algermissen, B. Hermes, B.M. Henz, and G. Kolde Successful treatment of chronic discoid lupus erythematosus with argon laser [in German] Hautarzt 47 1996 767 770 (Pubitemid 26362500)
48. D.L. Henderson, and J.C. Odom Laser treatment of discoid lupus (case report) Lasers Surg Med 6 1986 12 15 44-5 (Pubitemid 16141359)
49. S.L. Walker, and C.C. Harland Carbon dioxide laser resurfacing of facial scarring secondary to chronic discoid lupus erythematosus Br J Dermatol 143 2000 1101 1102
50. C. Raulin, C. Schmidt, and S. Hellwig Cutaneous lupus erythematosus-treatment with pulsed dye laser Br J Dermatol 141 1999 1046 1050 (Pubitemid 30046193)
51. A. Erceg, H.J. Bovenschen, P.C. van de Kerkhof, E.M. de Jong, and M.M. Seyger Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus J Am Acad Dermatol 60 2009 626 632
52. L. Molin, and M. Tarstedt Discoid lupus erythematosus treated with cryotherapy J Dermatolog Treat 14 2003 182 183 (Pubitemid 37254633)
53. S. Meller, B. Homey, and T. Ruzicka Socioeconomic factors in lupus erythematosus Autoimmun Rev 4 2005 242 246 (Pubitemid 40704710)
54. N. Sonnichsen, H. Meffert, V. Kunzelmann, and H. Audring UV-A-1 therapy of subacute cutaneous lupus erythematosus [in German] Hautarzt 44 1993 723 725 (Pubitemid 23338627)
55. H. McGrath Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus Clin Exp Rheumatol 12 1994 129 135
56. H. McGrath, P. Martinez-Osuna, and F.A. Lee Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus Lupus 5 1996 269 274 (Pubitemid 26306234)
57. M.C. Polderman, T.W. Huizinga, S. Le Cessie, and S. Pavel UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial Ann Rheum Dis 60 2001 112 115 (Pubitemid 32102200)
58. C.J. Sanders, H.Y. Lam, C.A. Bruijnzeel-Koomen, V. Sigurdsson, and H. van Weelden UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus J Am Acad Dermatol 54 2006 479 486 (Pubitemid 43243452)
59. H.J. Lee, and A.A. Sinha Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies Autoimmunity 39 2006 433 444 (Pubitemid 44575075)
60. T. Ruzicka, C. Sommerburg, G. Goerz, P. Kind, and H. Mensing Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine Br J Dermatol 127 1992 513 518
61. J. Wenzel, T. Bieber, M. Uerlich, and T. Tuting Systemic treatment of cutaneous lupus erythematosus J Dtsch Dermatol Ges 1 2003 694 704 (Pubitemid 37205280)
62. S. Kalia, and J.P. Dutz New concepts in antimalarial use and mode of action in dermatology Dermatol Ther 20 2007 160 174 (Pubitemid 350029307)
63. R. Lafyatis, M. York, and A. Marshak-Rothstein Antimalarial agents: closing the gate on Toll-like receptors? Arthritis Rheum 54 2006 3068 3070 (Pubitemid 44622073)
64. G. Ruiz-Irastorza, and M.A. Khamashta Hydroxychloroquine: the cornerstone of lupus therapy Lupus 17 2008 271 273 (Pubitemid 351655791)
65. J.F. Payne A postgraduate lecture on lupus erythematosus Clin J 4 1894 223 229
66. H. Martenstein Subacute lupus erythematosus and tubercular cervical adenopathy Zentralbl Haut Geschlechtskr 27 1928 248 249
67. F. Page Treatment of lupus erythematosus with mepacrine Lancet 2 1951 755 758
68. E.L. Dubois Antimalarials in the management of discoid and systemic lupus erythematosus Semin Arthritis Rheum 8 1978 33 51 (Pubitemid 9021790)
69. D.J. Wallace The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination Semin Arthritis Rheum 18 1989 282 296
70. D.J. Wallace Is there a role for quinacrine (Atabrine) in the new millennium? Lupus 9 2000 81 82 (Pubitemid 30171102)
71. N. Costedoat-Chalumeau, Z. Amoura, D.L. Huong, P. Lechat, and J.C. Piette Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: review of the literature Autoimmun Rev 4 2005 111 115 (Pubitemid 40255619)
72. F. Ochsendorf Antimalarials A. Kuhn, P. Lehmann, T. Ruzicka, Cutaneous lupus erythematosus 2004 Springer Heidelberg 347 372
73. C.L. Ziering, L.G. Rabinowitz, and N.B. Esterly Antimalarials for children: indications, toxicities, and guidelines J Am Acad Dermatol 28 1993 764 770 (Pubitemid 23133389)
74. J.T. Clarke, and V. Werth Therapy of cutaneous lupus erythematosus Expert Rev Dermatol 1 2006 105 120
75. R.D. Sontheimer Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary Arch Dermatol 136 2000 1044 1049 (Pubitemid 30629132)
76. F. Ochsendorf Systemic therapy of cutaneous lupus erythematosus J Dtsch Dermatol Ges 2 2004 229 230 (Pubitemid 38387409)
77. U. Gul, S.K. Cakmak, A. Kilic, M. Gonul, and S. Bilgili A case of hydroxychloroquine-induced pruritus Eur J Dermatol 16 2006 586 587
78. J. Jimenez-Alonso, J. Tercedor, L. Jaimez, and E. Garcia-Lora Antimalarial drug-induced aquagenic-type pruritus in patients with lupus Arthritis Rheum 41 1998 744 745 (Pubitemid 28214997)
79. R.D. Sontheimer Desensitization to hydroxychloroquine: alternative interpretations J Rheumatol 34 2007 253 255
80. M. Mates, S. Zevin, G.S. Breuer, P. Navon, and G. Nesher Desensitization to hydroxychloroquine-experience of 4 patients J Rheumatol 33 2006 814 816
81. M. Murphy, and A.J. Carmichael Fatal toxic epidermal necrolysis associated with hydroxychloroquine Clin Exp Dermatol 26 2001 457 458 (Pubitemid 32863107)
82. E.L. Callaly, O. FitzGerald, and S. Rogers Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis Clin Exp Dermatol 33 2008 572 574
83. G.D. Levy, S.J. Munz, J. Paschal, H.B. Cohen, K.J. Pince, and T. Peterson Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice Arthritis Rheum 40 1997 1482 1486 (Pubitemid 27430960)
84. A. Kuhn, E. Aberer, C. Barde, I. Foeldvari, M. Haust, and C. Iking-Konert Leitlinien Kutaner Lupus Erythematosus (Entwicklungsstufe 1) H.C. Korting, R. Callies, M. Reusch, M. Schlaeger, W. Sterry, Dermatologische Qualitätssicherung: Leitlinien und Empfehlungen 2009 ABW Wissenschaftsverlag GmbH Berlin
85. M.F. Marmor, R.E. Carr, M. Easterbrook, A.A. Farjo, and W.F. Mieler Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology Ophthalmology 109 2002 1377 1382 (Pubitemid 34700934)
86. A.S. Neubauer, K. Samari-Kermani, U. Schaller, U. Welge-Lubetaen, G. Rudolph, and T. Berninger Detecting chloroquine retinopathy: electro-oculogram versus color vision Br J Ophthalmol 87 2003 902 908 (Pubitemid 36765260)
87. M.F. Marmor The dilemma of hydroxychloroquine screening: new information from the multifocal ERG Am J Ophthalmol 140 2005 894 895 (Pubitemid 41727683)
88. T.Y. Lai, W.M. Chan, H. Li, R.Y. Lai, and D.S. Lam Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy Am J Ophthalmol 140 2005 794 807
89. E. Casado, J. Gratacos, C. Tolosa, J.M. Martinez, I. Ojanguren, and A. Ariza Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients Ann Rheum Dis 65 2006 385 390 (Pubitemid 43268230)
90. N. Costedoat-Chalumeau, J.S. Hulot, Z. Amoura, A. Delcourt, T. Maisonobe, and R. Dorent Cardiomyopathy related to antimalarial therapy with illustrative case report Cardiology 107 2007 73 80
91. M.R. Namazi The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine Lupus 18 2009 104 105
92. H.S. Chung, and S.K. Hann Lupus panniculitis treated by a combination therapy of hydroxychloroquine and quinacrine J Dermatol 24 1997 569 572
93. R. Feldmann, D. Salomon, and J.H. Saurat The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus Dermatology 189 1994 425 427 (Pubitemid 24358003)
94. S. Von Schmiedeberg, A.C. Rönnau, H.C. Schuppe, C. Specker, T. Ruzicka, and P. Lehmann Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus [in German] Hautarzt 51 2000 82 85 (Pubitemid 30164472)
95. E. Toubi, A. Kessel, I. Rosner, M. Rozenbaum, D. Paran, and Y. Shoenfeld The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus Scand J Immunol 63 2006 299 303
96. J. Wenzel, S. Brahler, R. Bauer, T. Bieber, and T. Tuting Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients Br J Dermatol 153 2005 157 162 (Pubitemid 41044542)
97. R. Lindskov, and F. Reymann Dapsone in the treatment of cutaneous lupus erythematosus Dermatologica 172 1986 214 217 (Pubitemid 16114429)
98. N. Creel, and V. Werth Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus J Drugs Dermatol 4 2005 225 227
99. L. Klareskog, L. Padyukov, and L. Alfredsson Smoking as a trigger for inflammatory rheumatic diseases Curr Opin Rheumatol 19 2007 49 54 (Pubitemid 44885727)
100. M. Harel-Meir, Y. Sherer, and Y. Shoenfeld Tobacco smoking and autoimmune rheumatic diseases Nat Clin Pract Rheumatol 3 2007 707 715 (Pubitemid 350187016)
101. H. Gallego, C.E. Crutchfield III, E.J. Lewis, and H.J. Gallego Report of an association between discoid lupus erythematosus and smoking Cutis 63 1999 231 234
102. H.A. Miot, L.D. Bartoli Miot, and G.R. Haddad Association between discoid lupus erythematosus and cigarette smoking Dermatology 211 2005 118 122 (Pubitemid 41160246)
103. P. Boeckler, M. Milea, A. Meyer, B. Uring-Lambert, E. Heid, and G. Hauptmann The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency Br J Dermatol 152 2005 265 270 (Pubitemid 40343596)
104. H. Polet The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes J Cell Physiol 122 1985 415 423 (Pubitemid 15127514)
105. J.R. Schein Cigarette smoking and clinically significant drug interactions Ann Pharmacother 29 1995 1139 1148
106. M.L. Jewell, and D.P. McCauliffe Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment J Am Acad Dermatol 42 2000 983 987 (Pubitemid 30368665)
107. P. Rahman, D.D. Gladman, and M.B. Urowitz Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus J Rheumatol 25 1998 1716 1719 (Pubitemid 28439264)
108. R. Hugel, T. Schwarz, and R. Glaser Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus Br J Dermatol 157 2007 1081 1083 (Pubitemid 47583525)
109. A. Kreuter, R. Gaifullina, C. Tigges, J. Kirschke, P. Altmeyer, and T. Gambichler Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking Arch Dermatol 145 2009 244 248
110. M.I. Costner, R.D. Sontheimer, and T.T. Provost Lupus erythematosus R.D. Sontheimer, T.T. Provost, Cutaneous manifestations of rheumatic diseases 2003 Williams & Wilkins Philadelphia 15 64
111. P. Boeckler, A. Cosnes, C. Frances, G. Hedelin, and D. Lipsker Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus Arch Dermatol 145 2009 1012 1016
112. S. Moghadam-Kia, K. Chilek, E. Gaines, M. Costner, M.E. Rose, and J. Okawa Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients Arch Dermatol 145 2009 255 260
113. J.W. Goldberg, and M.D. Lidsky Pulse methylprednisolone therapy for persistent subacute cutaneous lupus Arthritis Rheum 27 1984 837 838 (Pubitemid 14093737)